Macular Thickness in Intermediate Age-Related Macular Degeneration Is Influenced by Disease Severity and Subretinal Drusenoid Deposit Presence

被引:20
|
作者
Chiang, Trent Tsun-Kang [1 ]
Keenan, Tiarnan D. [2 ]
Agron, Elvira [2 ]
Liao, Jennifer [1 ]
Klein, Brandon [1 ]
Chew, Emily Y. [2 ]
Cukras, Catherine A. [2 ]
Wong, Wai T. [1 ]
机构
[1] NEI, Neuron Glia Interact Retinal Dis, NIH, 6 Ctr Dr,Bldg 6,Room 217, Bethesda, MD 20892 USA
[2] NEI, Div Epidemiol & Clin Applicat, NIH, 10 Ctr Dr,MSC 1204,Bldg 10,10 CRC,Room 3-253, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
reticular pseudodrusen; subretinal drusenoid deposits; intermediate age-related macular degeneration; optical coherence tomography; outcome measures; macular thickness; OUTER RETINAL ATROPHY; RETICULAR PSEUDODRUSEN; INFLAMMATION; ASSOCIATION; PREVALENCE; SCALE;
D O I
10.1167/iovs.61.6.59
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. To investigate how macular thickness varies with intermediate age-related macular degeneration (iAMD) severity and the presence of subretinal drusenoid deposits (SDDs). METHODS. A longitudinal prospective study of 143 participants >50 years of age with no to intermediate AMD who were followed with multimodal imaging and functional testing. Participants were stratified by iAMD severity according to imaging features. Macular thicknesses measurements over the central circles with 1-mm, 3-mm, and 6-mm diameters obtained from ocular coherence tomography imaging were compared across severity categories using cross-sectional (143 eyes) and longitudinal (subset of 77 eyes followed for 4 years) multivariate analyses. RESULTS. Compared with control eyes without large drusen or SDDs (Group 0), central maculas of lower risk eyes with unilateral large drusen (Group 1) were thicker (P = 0.014), whereas higher risk eyes with SDDs (Group SDD) were thinner (P = 0.02) in cross-sectional multivariate analyses. In longitudinal analyses, maculas with SDDs thinned more rapidly over 4 years relative to control eyes (P = 0.0058), which did not show significant thinning. More rapid central macular thinning was associated with worse baseline best-corrected visual acuity (BCVA) (P = 0.016) and more rapid BCVA decline (P = 0.0059). CONCLUSIONS. Macular thickness in iAMD varies with disease severity, showing small increases in eyes with large drusen and decreases in eyes with SDDs. Active processes possibly related to neuroinflammation and neurodegeneration may be contributory. Longitudinal central macular thickness evaluation is an accessible outcome measure relevant to functional measures and is potentially useful for iAMD interventional studies.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] CHOROIDAL THICKNESS AND VASCULARITY VARY WITH DISEASE SEVERITY AND SUBRETINAL DRUSENOID DEPOSIT PRESENCE IN NONADVANCED AGE-RELATED MACULAR DEGENERATION
    Keenan, Tiarnan D.
    Klein, Brandon
    Agron, Elvira
    Chew, Emily Y.
    Cukras, Catherine A.
    Wong, Wai T.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2020, 40 (04): : 632 - 642
  • [2] Subretinal drusenoid deposits, age-related macular degeneration, and cardiovascular disease
    Smith, R. Theodore
    Olsen, Timothy W.
    Chong, Victor
    Kim, Judy
    Hammer, Martin
    Lema, Gareth
    Deobhakta, Avnish
    Tan, Anna
    Tong, Yuehong
    Tai, Katy
    Fei, Yang
    Mordechaev, Emanuel
    Ledesma-Gil, Gerardo
    Otero-Marquez, Oscar
    Rosen, Richard B.
    Bhuiyan, Alauddin
    Sivaprasad, Sobha
    Rosenfeld, Philip J.
    ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY, 2024, 13 (01):
  • [3] Subretinal Drusenoid Deposits and the Loss of Rod Function in Intermediate Age-Related Macular Degeneration
    Tan, Rose
    Guymer, Robyn H.
    Luu, Chi D.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (10) : 4154 - 4161
  • [4] SUBRETINAL DRUSENOID DEPOSIT IN AGE-RELATED MACULAR DEGENERATION Histologic Insights Into Initiation, Progression to Atrophy, and Imaging
    Chen, Ling
    Messinger, Jeffrey D.
    Zhang, Yuhua
    Spaide, Richard F.
    Freund, K. Bailey
    Curcio, Christine A.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2020, 40 (04): : 618 - 631
  • [5] Macular Atrophy Development and Subretinal Drusenoid Deposits in Anti-Vascular Endothelial Growth Factor Treated Age-Related Macular Degeneration
    Zarubina, Anna V.
    Gal-Or, Orly
    Huisinghj, Carrie E.
    Owsley, Cynthia
    Freund, K. Bailey
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (14) : 6038 - 6045
  • [6] SUBRETINAL DRUSENOID DEPOSITS ASSOCIATED WITH PIGMENT EPITHELIUM DETACHMENT IN AGE-RELATED MACULAR DEGENERATION
    Alten, Florian
    Clemens, Christoph R.
    Milojcic, Carolin
    Eter, Nicole
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2012, 32 (09): : 1727 - 1732
  • [7] Correlation between ellipsoid zone thickness and the presence of subretinal drusenoid deposits in age-related macular degeneration
    Bellis, Raymond Matthew
    Fei, Yang
    Le, Brandon
    Ledesma-Gil, Gerardo
    Otero-Marquez, Oscar
    Tong, Yuehong
    Tai, Katy
    Rosen, Richard B.
    Lema, Gareth M. C.
    Smith, Roland Theodore
    BMJ OPEN OPHTHALMOLOGY, 2024, 9 (01):
  • [8] Association between Subretinal Drusenoid Deposits and Age-Related Macular Degeneration in Multimodal Retinal Imaging
    Krytkowska, Elzbieta
    Olejnik-Wojciechowska, Joanna
    Grabowicz, Aleksandra
    Safranow, Krzysztof
    Machalinska, Anna
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (24)
  • [9] Retinal Pigment Epithelium Degeneration Associated With Subretinal Drusenoid Deposits in Age-Related Macular Degeneration
    Xu, Xiaoyu
    Liu, Xing
    Wang, Xiaolin
    Clark, Mark E.
    McGwin, Gerald, Jr.
    Owsley, Cynthia
    Curcio, Christine A.
    Zhang, Yuhua
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2017, 175 : 87 - 98
  • [10] The Association Between Subretinal Drusenoid Deposits in Older Adults in Normal Macular Health and Incident Age-Related Macular Degeneration
    Huisingh, Carrie
    McGwin, Gerald, Jr.
    Neely, David
    Zarubina, Anna
    Clark, Mark
    Zhang, Yuhua
    Curcio, Christine A.
    Owsley, Cynthia
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (02) : 739 - 745